Macrophage migration inhibitory factor

Macrophage migration inhibitory factor (MIF) is a protein that in humans is encoded by the MIF gene. It is a cytokine involved in the regulation of the immune system and plays a critical role in the body's response to infection and inflammation.
Function[edit]
MIF is a pro-inflammatory cytokine that is released by various cells, including macrophages, T cells, and pituitary cells. It is involved in the regulation of macrophage function in host defense by inhibiting the random migration of these cells. MIF is also known to counteract the anti-inflammatory effects of glucocorticoids.
Mechanism of Action[edit]
MIF exerts its effects by binding to its receptor, CD74, which is expressed on the surface of immune cells. This interaction leads to the activation of several intracellular signaling pathways, including the MAPK/ERK pathway and the PI3K/Akt pathway. These pathways result in the production of other pro-inflammatory cytokines and the promotion of cell survival and proliferation.
Clinical Significance[edit]
Elevated levels of MIF have been associated with various autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease. MIF is also implicated in the pathogenesis of sepsis and cancer. Due to its role in inflammation and immune response, MIF is considered a potential therapeutic target for these conditions.
Research[edit]
Ongoing research is focused on understanding the precise role of MIF in disease processes and developing MIF inhibitors as potential therapeutic agents. Studies are also exploring the genetic regulation of MIF expression and its interaction with other cytokines and signaling molecules.
See Also[edit]
References[edit]
External Links[edit]
This cytokine related article is a stub. You can help WikiMD by expanding it.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian